Literature DB >> 8316080

Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance.

M E Levin1, G F Hatfull.   

Abstract

We have isolated RNA polymerase from Mycobacterium smegmatis and established conditions for specific transcription initiation in vitro. The M. smegmatis enzyme has a strong dependence on supercoiling of the DNA substrate for transcription from mycobacterial promoters. We also show that RNA polymerase is the target for rifampicin, and that this antibiotic specifically inhibits the transition from synthesis of short oligoribonucleotides to full-length transcripts. RNA polymerase isolated from a rifampicin-resistant mutant of M. smegmatis is less sensitive to rifampicin in vitro, confirming that one mechanism of rifampicin resistance in mycobacteria is through alteration of RNA polymerase. This in vitro transcription system provides a simple method for the characterization of gene expression in mycobacteria including the pathogens Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium leprae. It also provides a system for evaluating potential anti-mycobacterial drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316080     DOI: 10.1111/j.1365-2958.1993.tb01572.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  28 in total

1.  A mycobacterial extracytoplasmic function sigma factor involved in survival following stress.

Authors:  Q L Wu; D Kong; K Lam; R N Husson
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

2.  Characterization of the two Mycobacterium tuberculosis recA promoters.

Authors:  Krishna K Gopaul; Patricia C Brooks; Jean-François Prost; Elaine O Davis
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Sigma factor F does not prevent rifampin inhibition of RNA polymerase or cause rifampin tolerance in Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Claudia Sala; Sophie J Magnet; Jeffrey M Chen; Florence Pojer; Stewart T Cole
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

Review 5.  Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Authors:  Sumit Chakraborty; Kyu Y Rhee
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

6.  Mutational analysis of the mycobacteriophage BPs promoter PR reveals context-dependent sequences for mycobacterial gene expression.

Authors:  Lauren M Oldfield; Graham F Hatfull
Journal:  J Bacteriol       Date:  2014-08-04       Impact factor: 3.490

7.  Molecular basis of rifampin resistance in Streptococcus pneumoniae.

Authors:  T Padayachee; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

8.  The rpoB gene of Mycobacterium tuberculosis.

Authors:  L P Miller; J T Crawford; T M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.

Authors:  Yanmin Hu; Alireza Shamaei-Tousi; Yingjun Liu; Anthony Coates
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

10.  Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene.

Authors:  P Gaurivaud; F Laigret; J M Bove
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.